Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression

American Journal of Transplantation

Volumn 14, Issue 7, 2014, Pages 1599-1611

  Kawai, T ^a   Sachs, D H ^a   Sprangers, B ^b   Spitzer, T R ^a   Saidman, S L ^a   Zorn, E ^a   Tolkoff Rubin, N ^a   Preffer, F ^a   Crisalli, K ^a   Gao, B ^a   Wong, W ^b   Morris, H ^b   Locascio, S A ^b   Sayre, P ^c   Shonts, B ^b   Williams, W W ^a   Smith, R N ^a   Colvin, R B ^a   Sykes, M ^b   Cosimi, A B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c Immune Tolerance Network   (United States)

Author keywords

Chimerism; immunobiology; kidney transplantation; living donors; tolerance

Indexed keywords

ANTIBODY; B CELL ACTIVATING FACTOR; CALCINEURIN INHIBITOR; CD19 ANTIGEN; CD3 ANTIGEN; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DONOR SPECIFIC ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANEL REACTIVE ANTIBODY; PREDNISONE; RITUXIMAB; SIPLIZUMAB; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; ALLOANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ACUTE PYELONEPHRITIS; ADULT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CHIMERA; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG DOSE INCREASE; ELECTRON MICROSCOPY; FEMALE; GLOMERULUS BASEMENT MEMBRANE; GRAFT RECIPIENT; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LONG TERM CARE; LOW DRUG DOSE; MAINTENANCE IMMUNOSUPPRESSION; MALE; MIDDLE AGED; NERVE CELL; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RECURRENT DISEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; YOUNG ADULT; ALLOTRANSPLANTATION; BLOOD; CASE REPORT; FOLLOW UP; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGY; KIDNEY DISEASES; POSTOPERATIVE COMPLICATION; PROGNOSIS; TRANSPLANTATION TOLERANCE;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84903138587     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12731     Document Type: Article

References (39)

1. Lentine KL, Brennan DC, Schnitzler MA., Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005; 16: 496-506.
2. Alangaden GJ, Thyagarajan R, Gruber SA, et al. Infectious complications after kidney transplantation: Current epidemiology and associated risk factors. Clin Transplant 2006; 20: 401-409.
3. Marcen R., Immunosuppressive drugs in kidney transplantation: Impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs 2009; 69: 2227-2243.
4. Marchetti P, Navalesi R., The metabolic effects of cyclosporin and tacrolimus. J Endocrinol Invest 2000; 23: 482-490.
5. Billingham RE, Brent L, Medawar PB., Activity acquired tolerance of foreign cells. Nature 1953; 172: 603-606.
6. Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008; 358: 362-368.
7. Scandling JD, Busque S, Shizuru JA, Engleman EG, Strober S., Induced immune tolerance for kidney transplantation. N Engl J Med 2011; 365: 1359-1360.
8. Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant 2012; 12: 1133-1145.
9. Leventhal J, Abecassis M, Miller J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 2012; 4: 124ra28.
10. Sharabi Y, Sachs DH., Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493-502.
11. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256-262.
12. Kawai T, Sogawa H, Boskovic S, et al. CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant 2004; 4: 1391-1398.
13. Sykes M., Mixed chimerism and transplant tolerance. Immunity 2001; 14: 417-424.
14. Fuchimoto Y, Huang CA, Yamada K, et al. Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest 2000; 105: 1779-1789.
15. Spitzer TR, Delmonico F, Tolkoff-Rubin N, et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999; 68: 480-484.
16. Fudaba Y, Spitzer TR, Shaffer J, et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: In vivo and in vitro analyses. Am J Transplant 2006; 6: 2121-2133.
17. Spitzer TR, Sykes M, Tolkoff-Rubin N, et al. Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation 2011; 91: 672-676.
18. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353-361.
19. Farris AB, Taheri D, Kawai T, et al. Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant 2011; 11: 1464-1477.
20. Shaffer J, Villard J, Means TK, et al. Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. Exp Hematol 2007; 35: 1140-1152.
21. Platt MY, DeLelys ME, Preffer FI, Sohani AR., Flow cytometry is of limited utility in the early identification of "double-hit" B-cell lymphomas. Cytometry B Clin Cytom 2013; 84: 143-148.
22. LoCascio SA, Morokata T, Chittenden M, et al. Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation 2010; 90: 1607-1615.
23. Haas M, Racusen SB, Solez LC, et al. Banff 2013 meeting report: Inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014; 14: 272-283.
24. Andreola G, Chittenden M, Shaffer J, et al. Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation. Am J Transplant 2011; 11: 1236-1247.
25. Leventhal J, Abecassis M, Miller J, et al. Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: Durable chimerism predicts outcome. Transplantation 2013; 95: 169-176.
26. Zinkernagel RM, Althage A, Callahan G, Welsh RM Jr., On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J Immunol 1980; 124: 2356-2365.
27. Tomita Y, Khan A, Sykes M., Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1994; 153: 1087-1098.
28. Sykes M, Sachs DH., Mixed chimerism. Philos Trans R Soc Lond B Biol Sci 2001; 356: 707-726.
29. Kimikawa M, Sachs DH, Colvin RB, Bartholomew A, Kawai T, Cosimi AB., Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation 1997; 64: 709-716.
30. Kawai T, Cosimi AB, Wee SL, et al. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation 2002; 73: 1757-1764.
31. Tonsho MMT, Klarin D, Boskovic S, et al. Successful tolerance induction of cardiac allografts in nonhuman primates through donor kidney co-transplantation. Am J Transplant 2012; 13 (Suppl 5): 181-182.
32. Braun MY, McCormack A, Webb G, Batchelor JR., Evidence for clonal anergy as a mechanism responsible for the maintenance of transplantation tolerance. Eur J Immunol 1993; 23: 1462-1468.
33. Frasca L, Marelli-Berg F, Imami N, et al. Interferon-gamma-treated renal tubular epithelial cells induce allospecific tolerance. Kidney Int 1998; 53: 679-689.
34. Starke A, Lindenmeyer MT, Segerer S, et al. Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses. Kidney Int 2010; 78: 38-47.
35. Spitzer TR., Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893-898.
36. Kawai T, Poncelet A, Sachs DH, et al. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 1999; 68: 1767-1775.
37. Yamada Y, Boskovic S, Aoyama A, et al. Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates. Am J Transplant 2012; 12: 330-340.
38. Darce JR, Arendt BK, Chang SK, Jelinek DF., Divergent effects of BAFF on human memory B cell differentiation into Ig-secreting cells. J Immunol 2007; 178: 5612-5622.
39. Porcheray F, DeVito J, Helou Y, et al. Expansion of polyreactive B cells cross-reactive to HLA and self in the blood of a patient with kidney graft rejection. Am J Transplant 2012; 12: 2088-2097.